Hyperbaric Oxygen Therapy; Specialty Healthcare

NOT DISCLOSED, Pennsylvania

Asking Price	$1,695,000	Year Established
Annual Revenue	$1,049,784	Reason for Selling
Annual P/L	$0	Attention	John Geaneotes
Annual Cash Flow	$405,000	Listing Number	1010467
# of Employees		Business Category	Services: Medical, Dental

Business Overview:

Confidential opportunity to acquire a medically accredited hyperbaric oxygen therapy (HBOT) provider with 10+ years of operating history and strong Mid‑Atlantic presence. The company delivers medical‑grade HBOT across insurance and cash‑pay segments, generating ~$405K adjusted EBITDA on ~$1.05M revenue with ~38% margins. Balanced payor mix (~48% insurance / ~46% cash pay), no customer concentration, SBA‑financeable profile.

Operations run below full capacity (~40 patients/day vs. ~23 peak utilization), offering near‑term EBITDA upside through extended hours, modest staffing, and increased throughput—no major capital required. Patients typically complete ~40 sessions, yielding ~$28K per insurance patient and ~$9K per cash‑pay patient, creating predictable revenue streams. Accreditation by The Joint Commission, Medicare/commercial participation, multiplace chamber, and established referral network reinforce clinical credibility.

Growth levers include expanded hours, marketing investment, stronger physician referrals, and optimized scheduling. Transaction anticipated as stock sale, SBA‑supported, Mid‑Atlantic location disclosed post‑NDA. Well suited for owner‑operators, healthcare/wellness operators, and independent sponsors. Qualified buyers will receive detailed financials and operational data upon signing a confidentiality agreement.

Property Features and Assets:

Market Competition and Expansion:

Additional Details: